New Unitaid grants reach out to children with tuberculosis
Geneva – Unitaid’s Executive Board has approved two new grants worth a combined US$ 43.7 million to prevent tuberculosis in vulnerable populations, with an emphasis on curbing the devastating effects of TB on children.
The grants join two others approved in September to fund a US$ 117 million slate of new projects aimed at fighting the world’s leading infectious killer. The announcement coincides with a Unitaid event being held at the 48th Union World Conference on Lung Health in Guadalajara, Mexico.
“Every day, more than 200 children under the age of 15 die needlessly from TB, which is 200 deaths too many,” said Lelio Marmora, Unitaid Executive Director. “Integrating TB treatment into existing HIV and maternal and child health services will reach more children with life-saving treatment sooner.”
One of the two newly approved grants will provide US$ 36.3 million to improve treatment services, and the market, for child-friendly TB medicines, in India and nine African countries. Project leader Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will work to reach undiagnosed children by incorporating TB screening into services for HIV, nutrition, and maternal and child health. If the project is eventually scaled up globally, EGPAF estimates that over 500,000 lives could be saved over the five years following the project.
“Children with TB represent one of the most neglected and vulnerable populations in the world,” said Chip Lyons, EGPAF President and CEO. “EGPAF is proud to partner with Unitaid on this project that will expand our existing HIV prevention and treatment services to implement more effective diagnosis, treatment and care for children with active and latent TB.”
The second of the newly approved grants provides US$ 7.4 million to the World Health Organization’s (WHO) Global TB Programme as it works to improve the diagnosis and treatment of paediatric, latent and multidrug-resistant TB in high-burden countries. WHO will ensure that evidence generated from Unitaid investments is quickly put into global practice.
“The WHO Global TB Programme applauds Unitaid for this unprecedented move to enhance collaboration with WHO to combat TB,” said Dr Mario Raviglione, Director of WHO’s Global TB Programme. “Through this grant we will ensure that all TB-funded projects are structured and monitored in a way that outcomes are rapidly translated into innovative policies. I am particularly pleased with the decision to support work on latent TB infection, an orphan area which urgently requires generating stronger evidence for wider implementation.”
In 2015, 1.8 million people died of TB, about one person every 18 seconds. Without treatment, 45 percent of people with TB will die, as well as nearly all HIV-positive people with TB. WHO estimates that one million children developed TB in 2015, but more than half did not receive the diagnosis and treatment they needed, mostly those living in the poorest and most vulnerable households.
The pair of TB grants approved in September went to the Aurum Institute in South Africa (US$ 58.8 million) and the University of Bordeaux (US$ 14.6 million). The Aurum Institute will work with partners in a dozen countries in Africa, Asia and South America to expand short-course preventive therapy for two groups at especially high risk for TB: people living with HIV and children under five years old. The University of Bordeaux will concentrate on widening the availability of childhood TB diagnosis in six African countries and Cambodia, using fast, state-of-the-art tests that can be performed even in small local clinics.
Leer en español [PDF, 212KB]
Leaders say action targeting women, children and adolescents key to meeting health SDG
New York – Over the next twelve years, the world will face an enormous challenge to ensure health for women, children and adolescents while seeking to achieve the Sustainable Development Goals (SDGs).
We therefore call on Heads of State and Government to put reproductive, maternal, newborn, child and adolescent health at the core of efforts to accelerate the global response against HIV/AIDS, tuberculosis, and malaria and to reach ambitious global health goals by 2030.
Based on successful strategies and experiences, we invite countries to attain our shared commitments by:
- Reducing inequities among populations and promoting health as a fundamental human right;
- Increasing investments in innovative approaches to achieve SDG 3, and its associated targets, that help to ensure healthy lives and promote well-being for everyone at all ages;
- Creating and improving innovative financing mechanisms for health;
- Accelerating access to innovative health products, quality health services and adequate support for most vulnerable populations, particularly women, children and adolescents.
- Strengthening the coordination of the global health response and the collaboration between health stakeholders at global, regional and country level;
- Ensuring predictable and sustainable global and domestic funding to intensify the global response by aiming to meet a target of committing 0.7% of developed countries’ gross national income to official development assistance.
Meeting the challenge of achieving the SDGs and ensuring the health of women, children and adolescents is a crucial step towards bringing about healthy and robust economies, politically stable societies and resilient communities. The health of women, children and adolescents is critically important to virtually every area of human development and progress, and directly affects the success of the international community in accordance with global commitments.
H.E. Ms Michelle Bachelet H.E. Mr Celso Amorim
President of Chile Chair of the Executive Board of Unitaid
Signed on the occasion of the High-level Breakfast held on 21 September 2017 during 72nd session of the United Nations General Assembly in New York
Tuberculosis diagnostics technology landscape – 5th edition
Preventing mother-to-child HIV transmission
Addressing neglected childhood tuberculosis
